Makoto Kawai
Neurology · Belmont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 4 carriers
- Offices
- 4
Offices
4 locations · Dignity Health Medical Foundation · Stanford Health Care
Hospitals listed: Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Makoto Kawai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C54396 · Current
Licensed to practise in California · since 2010 · expires 2028-07-31 · Kyoto University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas N1706Physician License · since 2008 · expires 2024-08-31Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$79,113
Medicare paid this office $79,113 for 453 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 204 | $39,372 | $150 |
| Sleep study in sleep lab (6 years or older) | 93 | $9,744 | $105 |
| New patient visit (60+ min) | 47 | $7,437 | $158 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 61 | $6,611 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,818 | $123 |
See all 11 services
| Long return visit (40+ min) | 204 | $39,372 | $150 |
| Sleep study in sleep lab (6 years or older) | 93 | $9,744 | $105 |
| New patient visit (60+ min) | 47 | $7,437 | $158 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 61 | $6,611 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,818 | $123 |
| Return visit (30+ min) | 25 | $2,670 | $99 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 19 | $2,044 | $79 |
| New patient visit (45+ min) | 17 | $1,981 | $117 |
| Sleep study including heart rate, breathing, and sleep time | 47 | $1,602 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,533 | $73 |
| Short return visit (20+ min) | 16 | $993 | $62 |
Who their Medicare patients are
453 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 12% · Women 45% · Also on Medicaid 16% · Health risk score 1.25. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Coronary heart disease 32% · Diabetes 27% · Atrial fibrillation 26% · Depression 25% · Chronic kidney disease 22% · Heart failure 18% · Cancer 17% · Stroke 16% · Dementia 12% · COPD 11%.
The office billed $596,127, Medicare allowed $103,589 and paid $79,113; for 678 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 453 | 678 | 74 | 1.25 | $596,127 | $79,113 |
| 2023 | 378 | 578 | 73 | 1.28 | $436,778 | $61,925 |
| 2022 | 252 | 354 | 73 | 1.13 | $224,955 | $36,188 |
| 2021 | 247 | 327 | 73 | 1.16 | $261,438 | $37,819 |
| 2020 | 240 | 338 | 73 | 1.37 | $191,115 | $29,704 |
| 2019 | 281 | 381 | 74 | 1.54 | $117,137 | $34,072 |
| 2018 | 205 | 288 | 73 | 1.43 | $71,631 | $25,478 |
| 2017 | 244 | 396 | 71 | 1.18 | $123,413 | $35,330 |
| 2016 | 208 | 285 | 72 | 1.31 | $85,972 | $21,881 |
| 2015 | 115 | 154 | 71 | 1.17 | $33,036 | $9,526 |
| 2013 | 281 | 801 | 70 | 3.47 | $275,072 | $102,010 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Long return visit (40+ min) | 183 | $28,723 | $120 |
| Sleep study in sleep lab (6 years or older) | 86 | $8,755 | $102 |
| New patient visit (60+ min) | 51 | $7,761 | $152 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 40 | $4,326 | $108 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 28 | $2,833 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,471 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,082 | $72 |
| Sleep study including heart rate, breathing, and sleep time | 32 | $1,158 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,042 | $69 |
2022: 6 services
| Long return visit (40+ min) | 140 | $19,463 | $116 |
| New patient visit (60+ min) | 35 | $4,501 | $129 |
| Sleep study in sleep lab (6 years or older) | 40 | $4,322 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,239 | $61 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $1,905 | $106 |
| Sleep study including heart rate, breathing, and sleep time | 20 | $683 | $34 |
2021: 5 services
| Long return visit (40+ min) | 165 | $26,232 | $126 |
| New patient visit (60+ min) | 33 | $5,266 | $160 |
| Sleep study in sleep lab (6 years or older) | 16 | $1,768 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,626 | $65 |
| Sleep study including heart rate, breathing, and sleep time | 14 | $532 | $38 |
2020: 4 services
| Long return visit (40+ min) | 150 | $15,760 | $90 |
| New patient visit (60+ min) | 33 | $4,543 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,479 | $65 |
| Sleep study in sleep lab (6 years or older) | 17 | $1,795 | $106 |
2019: 6 services
| Long return visit (40+ min) | 159 | $19,171 | $89 |
| Sleep study in sleep lab (6 years or older) | 48 | $5,213 | $106 |
| New patient visit (60+ min) | 24 | $2,871 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,511 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,241 | $89 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 14 | $1,107 | $79 |
2018: 5 services
| Long return visit (40+ min) | 140 | $16,693 | $89 |
| New patient visit (60+ min) | 15 | $2,235 | $149 |
| Sleep study in sleep lab (6 years or older) | 19 | $2,025 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,488 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,067 | $89 |
2017: 5 services
| Long return visit (40+ min) | 172 | $23,074 | $94 |
| New patient visit (60+ min) | 29 | $3,549 | $122 |
| Sleep study in sleep lab (6 years or older) | 24 | $2,545 | $106 |
| Return visit (30+ min) | 50 | $2,347 | $45 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,212 | $101 |
2016: 6 services
| Return visit (30+ min) | 102 | $9,426 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,796 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,252 | $64 |
| Sleep study in sleep lab (6 years or older) | 17 | $1,866 | $110 |
| Short return visit (20+ min) | 25 | $1,096 | $42 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,071 | $89 |
2015: 4 services
| Return visit (30+ min) | 28 | $2,431 | $69 |
| Short return visit (20+ min) | 40 | $2,022 | $45 |
| New patient visit (30+ min) | 14 | $942 | $67 |
| New patient visit (15+ min) | 15 | $667 | $44 |
2013: 8 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 59 | $56,945 | $255 |
| Monitoring and localization of seizure activity over 24-hour period using electroencephalograph (EEG) | 81 | $24,380 | $149 |
| Measurement of brain wave activity (eeg), awake and drowsy | 142 | $6,635 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,942 | $54 |
| Short return visit (20+ min) | 53 | $2,790 | $38 |
| Measurement of brain wave activity (eeg), awake and asleep | 37 | $1,526 | $41 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,347 | $79 |
| Return visit (30+ min) | 11 | $764 | $69 |
Drugs they prescribed that Part D paid
$117,140
Pharmacies billed $117,140 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 10% of their Part D prescriptions (25 of 251) in 2024. A higher opioid share than 9 in 10 peers; the typical neurology clinician is at 0%. Long-acting opioids: 76% of their opioid prescriptions.
214 generic and 37 brand-name prescriptions · $117,140 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 16 | $6,783 | $424 |
| Modafinil | 14 | $497 | $36 |
| Eszopiclone | 15 | $390 | $26 |
| Gabapentin | 26 | $318 | $12 |
| Zolpidem | 29 | $301 | $10 |
See all 9 drugs
| Belsomra | 16 | $6,783 | $424 |
| Modafinil | 14 | $497 | $36 |
| Eszopiclone | 15 | $390 | $26 |
| Gabapentin | 26 | $318 | $12 |
| Zolpidem | 29 | $301 | $10 |
| Trazodone | 21 | $240 | $11 |
| Methadone | 17 | $232 | $14 |
| Methylphenidate | 13 | $132 | $10 |
| Ropinirole | 12 | $47 | $4 |
Year by year
| 2024 | 251 | 55 | 10% (25) | 15% | $117,140 |
| 2023 | 135 | 27 | 10% (14) | 13% | $22,148 |
| 2022 | 94 | 22 | None | 13% | $10,683 |
| 2021 | 138 | 26 | None | None | $231,461 |
| 2020 | 90 | 22 | None | 28% | $14,928 |
| 2019 | 92 | 25 | None | 15% | $11,543 |
| 2018 | 72 | 19 | 0% (0) | 28% | $10,868 |
| 2017 | 117 | 26 | 0% (0) | 14% | $10,090 |
| 2016 | 46 | 12 | 0% (0) | None | $5,131 |
| 2015 | 19 | None | 0% (0) | None | $515 |
| 2014 | 54 | 19 | None | 33% | $10,869 |
| 2013 | 312 | 46 | None | None | $56,245 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Ropinirole | 11 | $596 | $54 |
| Gabapentin | 14 | $229 | $16 |
| Zolpidem | 24 | $209 | $9 |
| Eszopiclone | 12 | $115 | $10 |
| Trazodone | 12 | $95 | $8 |
2022: 2 drugs
| Zolpidem | 34 | $243 | $7 |
| Gabapentin | 11 | $84 | $8 |
2021: 4 drugs
| Xyrem | 11 | $192,116 | $17,465 |
| Triazolam | 11 | $1,941 | $176 |
| Venlafaxine Hcl Er | 12 | $144 | $12 |
| Zolpidem | 17 | $89 | $5 |
2020: 2 drugs
| Armodafinil | 12 | $3,990 | $332 |
| Mirtazapine | 12 | $249 | $21 |
2019: 2 drugs
| Mirtazapine | 11 | $123 | $11 |
| Zolpidem | 18 | $110 | $6 |
2018: 1 drug
| Clonazepam | 12 | $126 | $10 |
2017: 6 drugs
| Modafinil | 12 | $1,815 | $151 |
| Pramipexole Dihydrochloride | 15 | $472 | $31 |
| Eszopiclone | 24 | $301 | $13 |
| Gabapentin | 11 | $169 | $15 |
| Fluticasone Propionate | 16 | $121 | $8 |
| Clonazepam | 11 | $23 | $2 |
2016: 1 drug
| Clonazepam | 15 | $400 | $27 |
2014: 1 drug
| Levetiracetam | 16 | $1,078 | $67 |
2013: 8 drugs
| Vimpat | 12 | $10,707 | $892 |
| Lamictal Xr | 18 | $9,704 | $539 |
| Levetiracetam | 97 | $8,580 | $88 |
| Lyrica | 22 | $3,226 | $147 |
| Oxcarbazepine | 21 | $2,877 | $137 |
| Depakote Er | 11 | $2,089 | $190 |
| Lamotrigine | 26 | $1,534 | $59 |
| Topiramate | 13 | $804 | $62 |
Money from drug and device companies
$996 in 2022
A payment is not proof that care is biased.
| FUKUDA DENSHI Co. | None | $996 | 1 payment
|
See the published payment
| FUKUDA DENSHI Co. | Honoraria · 2022-10-25 | None | $996 |
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Functional Neuromodulation Inc · Advance II · 2021 | Their institution | $118,728 |
| Functional Neuromodulation Inc · Advance II · 2022 | Their institution | $15,522 |
| Functional Neuromodulation Inc · Advance II · 2023 | Their institution | $6,007 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1215175856
- Licence
- CA C54396, TX N1706California C54396: Current · expires 2028-07-31Texas N1706: Canc Non-Renewal
- Group
- Dignity Health Medical Foundation · Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NY 03158005, TX 206447901
- Taxonomy
- Federal specialty code 2084S0012X (2084S0012X); Neurology (2084N0400X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2009-02-04
- NPI last updated
- 2024-04-30
- NPI record certified
- 2024-04-30
This is when the NPI record was last certified, not a medical board exam.